TECOmedical AG Logo

PKA - PreKallikrein Activator

The determination of prekallikrein activator (PKA) levels is a requirement for batch release of human albumin and immunoglobulin preparations according to the European and US Pharmacopoeia guidelines.

According to the Pharmacopoeia guidelines, PKA assays are performed using a Prekallikrein pool, produced in-house or purchased commercially, and an externally sourced chromogenic substrate and PKA standard. The in-house production of the Prekallikrein pool is time-consuming and technically difficult to perform consistently.

The new alternative from Eurobio Scientific for batch release testing:
• a ready-to-use Prekallikrein Pool together with your separate components
• our complete PKA assay kits

Key features
• Assay kits of matched reagents that are Pharmacopoeia compliant
• Standard & mid-level kit control calibrated against the 3rd International Standard for PKA
• Assay reliability and continuity with minimal batch-to-batch variation
• Unique high-blank blocking reagent to accurately measure PKA levels in immunoglobulin preparations,
even at low levels
• New lyophilised Prekallikrein Pool that is quick and easy to reconstitute to a clear solution that is stable
for up to 6 months
• High activity for improved assay sensitivity
• Long shelf life and large batch sizes enabling continuity across multiple testing centres
• Separate high and low PKA accuracy controls for use in any PKA test configuration